Cargando…

Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome

INTRODUCTION: It is still controversial whether borderline lesions with a vulnerable plaque should be stented early or simply treated pharmacologically. No data exist concerning the potential effects of statin therapy on borderline vulnerable lesions in patients with acute coronary syndrome (ACS). M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dan-Qing, Lin, Shu-Guang, Chen, Ji-Yan, Xue, Ling, Li, Guang, Dong, Hao-Jian, Zhou, Ying-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2011
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258749/ https://www.ncbi.nlm.nih.gov/pubmed/22295025 http://dx.doi.org/10.5114/aoms.2011.23408

Ejemplares similares

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
por: Zhou, Langping, et al.
Publicado: (2023)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Comparative Effectiveness of Generic Atorvastatin and Lipitor(®) in Patients Hospitalized with an Acute Coronary Syndrome
por: Jackevicius, Cynthia A., et al.
Publicado: (2016)

Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome
por: Khurana, Sushant, et al.
Publicado: (2015)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients with Acute Coronary Syndrome
por: Kumar, Besham, et al.
Publicado: (2019)

Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease
por: Gu, Guo-Long, et al.
Publicado: (2014)

Effects of Atorvastatin in Patients with Acute Spinal Cord Injury
por: Aghazadeh, Javad, et al.
Publicado: (2017)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia
por: Peng, You, et al.
Publicado: (2018)

Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome
por: Vondrakova, Dagmar, et al.
Publicado: (2010)

Postoperative Assessment of Myocardial Function and Microcirculation in Patients with Acute Coronary Syndrome by Myocardial Contrast Echocardiography
por: Jiang, Li, et al.
Publicado: (2017)

A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project
por: Ran, Peng, et al.
Publicado: (2021)

Identification of vulnerable non-culprit lesions by coronary computed tomography angiography in patients with chronic coronary syndrome and diabetes mellitus
por: Zhao, Jia, et al.
Publicado: (2023)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after percutaneous coronary intervention
por: Gu, Ling-Feng, et al.
Publicado: (2023)

Retinal artery lesions and long-term outcome in Chinese patients with acute coronary syndrome
por: Wang, J, et al.
Publicado: (2015)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
por: Jia, Si-Da, et al.
Publicado: (2020)

Therapeutic effects of different Atorvastatin doses on vulnerable plaques in coronary arteries assessed by intracoronary optical coherence tomography
por: Ye, Honghua, et al.
Publicado: (2018)

The Vulnerable Plaque: the Real Villain in Acute Coronary Syndromes
por: Liang, Michael, et al.
Publicado: (2011)

Diagnosis and Treatment of Borderline Lesions
Publicado: (2002)

Acute One-Stop Cardiovascular Magnetic Resonance Imaging for Differential Diagnosis in Patients with Acute Coronary Syndrome and Unobstructed Coronary Arteries
por: Chu, Guang, et al.
Publicado: (2015)

The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study
por: Xue, Chao, et al.
Publicado: (2022)

MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome
por: Li, Miao-Nan, et al.
Publicado: (2017)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndrome
por: Zamani, Bijan, et al.
Publicado: (2014)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: A meta-analysis
por: Li, Ying-Qing, et al.
Publicado: (2014)

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
por: Lee, Bong-Ki, et al.
Publicado: (2016)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

Borderline Personality Disorder (BPD): In the Midst of Vulnerability, Chaos, and Awe
por: Kulacaoglu, Filiz, et al.
Publicado: (2018)

Circulating Th22 and Th9 Levels in Patients with Acute Coronary Syndrome
por: Lin, Ying-zhong, et al.
Publicado: (2013)

Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011)

Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
por: Peng, Shi, et al.
Publicado: (2018)

Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study
por: Kabaklić, Amela, et al.
Publicado: (2017)

Intravascular ultrasound characteristics in patients with intermediate coronary lesions and borderline fractional flow reserve measurements
por: Yang, Hyoung-Mo, et al.
Publicado: (2018)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014)

Greenselect Phytosome for Borderline Metabolic Syndrome
por: Belcaro, Gianni, et al.
Publicado: (2013)

Autonomic vulnerability to biased perception of social inclusion in borderline personality disorder
por: Lidia, Gerra Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a18es3gms7roh59glsq51fec02